PL3262420T3 - Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2 - Google Patents

Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2

Info

Publication number
PL3262420T3
PL3262420T3 PL16714534T PL16714534T PL3262420T3 PL 3262420 T3 PL3262420 T3 PL 3262420T3 PL 16714534 T PL16714534 T PL 16714534T PL 16714534 T PL16714534 T PL 16714534T PL 3262420 T3 PL3262420 T3 PL 3262420T3
Authority
PL
Poland
Prior art keywords
diabetes
type
early diagnosis
diabetic state
diabetic
Prior art date
Application number
PL16714534T
Other languages
English (en)
Inventor
Agnieszka Dobrzyń
Kamil Koziński
Tomasz Bednarski
Paweł Dobrzyń
Original Assignee
Inst Biologii Doswiadczalnej Im M Nenckiego Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Biologii Doswiadczalnej Im M Nenckiego Polskiej Akademii Nauk filed Critical Inst Biologii Doswiadczalnej Im M Nenckiego Polskiej Akademii Nauk
Publication of PL3262420T3 publication Critical patent/PL3262420T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL16714534T 2015-02-26 2016-02-26 Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2 PL3262420T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL411390A PL411390A1 (pl) 2015-02-26 2015-02-26 Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2, oraz jej powikłań, w szczególności kardiomiopatii cukrzycowej
EP16714534.1A EP3262420B1 (en) 2015-02-26 2016-02-26 A method for the early diagnosis of a pre-diabetic state and type 2 diabetes
PCT/IB2016/051087 WO2016135702A1 (en) 2015-02-26 2016-02-26 A method for the early diagnosis of a pre-diabetic state and type 2

Publications (1)

Publication Number Publication Date
PL3262420T3 true PL3262420T3 (pl) 2019-11-29

Family

ID=55661489

Family Applications (2)

Application Number Title Priority Date Filing Date
PL411390A PL411390A1 (pl) 2015-02-26 2015-02-26 Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2, oraz jej powikłań, w szczególności kardiomiopatii cukrzycowej
PL16714534T PL3262420T3 (pl) 2015-02-26 2016-02-26 Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL411390A PL411390A1 (pl) 2015-02-26 2015-02-26 Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2, oraz jej powikłań, w szczególności kardiomiopatii cukrzycowej

Country Status (5)

Country Link
US (1) US10222384B2 (pl)
EP (1) EP3262420B1 (pl)
ES (1) ES2731294T3 (pl)
PL (2) PL411390A1 (pl)
WO (1) WO2016135702A1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007027509A2 (en) * 2005-08-31 2007-03-08 Biogen Idec Ma Inc. Evaluating and treating scleroderma
JP2010519913A (ja) * 2007-03-02 2010-06-10 エムディーアールエヌエー,インコーポレイテッド Wnt遺伝子の発現を抑制するための核酸化合物およびその使用
JP5246870B2 (ja) * 2009-03-25 2013-07-24 独立行政法人産業技術総合研究所 インシュリン産生増強剤
BR112013020274A2 (pt) 2011-02-10 2016-11-22 Harvard College substitutos de proteínas pós-traducionalmente modificadas e usos dos mesmos

Also Published As

Publication number Publication date
EP3262420A1 (en) 2018-01-03
US10222384B2 (en) 2019-03-05
PL411390A1 (pl) 2016-08-29
US20180017574A1 (en) 2018-01-18
WO2016135702A1 (en) 2016-09-01
EP3262420B1 (en) 2019-03-20
ES2731294T3 (es) 2019-11-14

Similar Documents

Publication Publication Date Title
EP3355768A4 (en) Quantitative heart testing
EP3173027A4 (en) Heart failure evaluation method and diagnosis device
PL2910178T3 (pl) Układ do diagnostyki przewodu żołądkowo-jelitowego i sposób sterowania tym układem
GB201719423D0 (en) Diagnostic tests
IL271534A (en) Immunosignatures for differential diagnosis
GB201612165D0 (en) Combinations for the treatment of type 2 diabetes
EP3256859A4 (en) A biomarker for diagnosing vascular diseases and the uses thereof
GB201507827D0 (en) Diagnostic test
GB201500875D0 (en) Antibodies for treatment and diagnosis
GB201402036D0 (en) Method for determination of the status of a disease
IL267982A (en) diagnosis
GB2539632B (en) An apparatus for assisting with the application of a garment
EP3734277A4 (en) PROCESS FOR EVALUATING A MEDICINAL PRODUCT
GB201508860D0 (en) Diagnostic method
GB201615753D0 (en) Diagnostic method
IL251879A0 (en) A method for diagnosing Niemann-Pick disease using a biomarker
IL258049A (en) A sensor that allows visualization of a catheter
GB201504297D0 (en) Diagnosis
GB201509658D0 (en) Method of diagnosis
PL3262420T3 (pl) Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2
EP3535421C0 (en) DIAGNOSTIC PROCEDURES
GB201615330D0 (en) Method of diagnosis
GB201410118D0 (en) Early diagnosis of leptospire
GB2570772B (en) Integrity monitor
GB201717509D0 (en) Method of diagnosis